welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Thetis Pharmaceuticals Awarded Key Patent on HEALER Technology
Thetis Pharmaceuticals LLC, a privately-held biopharmaceutical company focused on gastrointestinal and cardiometabolic diseases, announced today that the USPTO has granted patent US 9,242,008 providing composition of matter protection for two Thetis development candidates, TP-252 for familial adenomatous polyposis and TP-452 for dyslipidemia. The allowed claims include pharmaceutical compositions that are mineral amino-acid based derivatives of fatty acids. National filings outside of the United States are underway.
expertly curated content related to this topic
- Danielle C. Bonadies, MSShe served as an Assistant Director, Yal...
- Chemoprevention of Colorectal NeoplasiaBACKGROUND : Colorectal cancer is a comm...
- Familial Adenomatous Polyposis (FAP) Cancer Prevention Pharmaceuticals FAP-310 Clinical Trial Overviewhttps://vimeo.com/144542413...
- @FAPStudyDo you suffer from F.A.P.? There's a cli...
- Ureteric Obstruction in Familial Adenomatous Polyposis-Associated Desmoid DiseasePURPOSE : Intra-abdominal desmoid diseas...
English
Portuguese